Statistics for Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab Plus Carboplatin and Etoposide Chemotherapy (Pembrolizumab-Chemotherapy) or Chemotherapy Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)
Total visits
| views | |
|---|---|
| Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab Plus Carboplatin and Etoposide Chemotherapy (Pembrolizumab-Chemotherapy) or Chemotherapy Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC) | 0 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |